Analysis of the assortment of immunobiological medical products used for children routine immunization at the Ukrainian pharmaceutical market
DOI:
https://doi.org/10.24959/nphj.15.2006Keywords:
immunobiological medical products, routine immunization, pharmaceutical marketAbstract
Marketing analysis of the assortment structure of immunobiological medical products (IMP) used for children routine immunization has been described in the article. It has been found that the given group of products is represented at the Ukrainian pharmaceutical market by 34 trade names, 65% of which belong to foreign producers, 35% are produced by domestic manufacturers. Among the foreign countries-manufacturers of IMP for children routine immunization Belgium takes the leading place, the share of its registered trade names is 29% of this segment. According to the results of the analysis it has been found that manufacturing a number of vaccines mostly from the foreign “in bulk” form is the feature of domestic IMP production. In particular, such production method for vaccines is used by “PHARMA LIFE” company (Lviv), which forms 33% of the domestic vaccine assortment, and “PHARMEX GROUP” company (Boryspil, Kyiv region), and it is 17% of the assortment. Only “PHARMSTANDARD-BIOLIK” company (Kharkiv) provides the production of vaccines from their own raw materials and forms 50% of the domestic vaccine assortment. During the research vaccines were divided by the amount and direction of action of the components, and mono- and multicomponent vaccines were distributed by the countries-manufacturers. It has been found that mono- and mul-ticomponent vaccines are represented at the Ukrainian pharmaceutical market in an equal amount – 17 trade names. Among the countries-manufacturers of monovaccines the leading place belongs to Ukraine (17.6% of the assortment), among the manufacturers of multicomponent vaccines Belgium takes the first place representing 41% of the assortment. The results of the marketing analysis show the dependence of the Ukrainian market of vaccines, especially multicomponent ones, on import and determine the need for further study of the availability level of IMP for children routine immunization.References
Державний реєстр лікарських засобів України. [Електронний ресурс]. – Режим доступу: http://www.drlz.kiev.ua/.
Компендиум on-line. [Електронний ресурс]. – Режим доступу: http://compendium.com.ua/.
Котвицкая А.А., Кононенко О.В.// Материалы 4-ой Международной науч.-практ. конф. студентов и молодых учених «Фармацевтический кластер как интеграция науки, образования и производства». – Белгород.: ИД «Белгород» НИУ БелГУ, 2013. – С. 13 – 15.
Котвіцька А.А., Кононенко О.В.// Матеріали II міжн. наук.-практ. Internet-конф. «Менеджмент та маркетинг у складі сучасної економіки, науки, освіти, практики». – Харків.: Вид-во НФаУ, 2014. – С. 245 - 246.
Марієвський В.Ф. // Сучасні інфекції. – 2009. – № 3-4. – C. 7 – 11.
Наказ МОЗ України від 16.09.2011 № 595 «Про порядок проведення профілактичних щеплень в Україні та контроль якості й обігу медичних імунобіологічних препаратів». [Електронний ресурс]. – Режим доступу: http://zakon3.rada.gov.ua/laws /show/z1159-11.
Платов С.М, Заглада О.О., Мендрік О.А.// Клиническая иммунология. Аллергология. Инфектология. – № 2 – 2011. – С. 11 – 15.
Устінов О. В., Чудутова Д.// Укр. Мед. часопис. – №5(79). – 2010. – С. 33 – 36.
Advani A. Epidemiological characterisation of Bordetella pertussis in Sweden, 1970–2004. – Stockholm, 2007. – P. 1–59.
Edelman K., He Q., Mäkinen J. et al. // Clin. Infect. Dis. – 2007. – Vol. 44. – P. 1271–1277.
Keith J.A., Bigger L.A., Arthur P.A. et al. // Vaccine – 2013. – Vol. 31. – P. 184– 193.
Mast E.E., Ward J.W. // Vaccines 5th edition. – China. – 2008 – P. 205–241.
Offit P.A., Quarles J., Gerber M.A. et al. // Pediatrics. – 2003. – Vol. 109. – Р. 124-29.
Orenstein, W.A., Rodewald L.E., Hinman A.R. et al. // Vaccines 5th edition. – China. – 2008 – P. 1479–1510.
Plotkin S., Stanley A., Walter Orenstein et al. // Vaccines, 5th edition. – China. – 2008 – 1748 P.
Plotkin S.L., Plotkin S.A. // Vaccines 5th edition. – China. – 2008 – P. 345–357.
Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). – 2005. – Vol. 48. [Електронний ресурс]. – Режим доступу: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4805a1.htm.
Swedish Institute for Infectious Disease Control.– Ten year Report: October 1, 1997 until December 31, 2007. – P. 1–53.
Taylor Kate, Nguyen Aurélia, Stéphenne Jean // Vaccine – 2009. – Vol. 27. – P. 3–8.
WHO, UNICEF, World Bank. State of the world’s vaccines and immunization, 3rd ed. Geneva, World Health Organization, 2009. [Електронний ресурс]. – Режим доступу: http://whqlibdoc.who.int/publications/2009/97892415 63864_eng.pdf.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
